Clare Leech
Merck & Co.
3 Papers
54 Citations
Clare Leech is an academic researcher from Merck & Co.. The author has contributed to research in topics: Dynamic priority scheduling & Job scheduler. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
The search for novel TRPV1-antagonists: From carboxamides to benzimidazoles and indazolones
Stephen Robert Fletcher,Edward Giles Mciver,Stephen John Lewis,Frank Burkamp,Clare Leech,G Mason,Susan Boyce,Denise Morrison,Gillian R. Richards,Kathy G Sutton,Anthony B. Jones +10 more
TL;DR: Based on a series of diaryl amides the corresponding inverse amides have been found to be potent TRPV1 receptor antagonists and indazolone 4a was identified as a novel TRPv1 receptor antagonist suitable for evaluating orally in animal models of analgesia.
63
Implementation of a High Specification Dual-Arm Robotic Platform to Meet Flexible Screening Needs
Kevin W. Moore,Robert J. Newman,Grace K.Y. Chan,Clare Leech,Karen Allison,Jo Coulson,Peter B. Simpson +6 more
TL;DR: MSD with RTS Life Science have developed and installed a dual-robot arm screening system at the Terlings Park site to support early stage drug discovery.
18
A cell-based ultra-high-throughput screening assay for identifying inhibitors of D-amino acid oxidase
Philip E. Brandish,Chi-Sung Chiu,Jonathan Schneeweis,Nicholas J. Brandon,Clare Leech,Oleg Kornienko,Edward M. Scolnick,Berta Strulovici,Wei Zheng +8 more
TL;DR: The authors have identified several cell-permeable inhibitors of DAO from this cell-based high-throughput screening, which provided the discovery program with a few novel and attractive lead structures.